Literature DB >> 19052735

Drug use in pregnancy--physicians' evaluation of quality and clinical impact of drug information centres.

Sofia Kristina Frost Widnes1, Jan Schjøtt.   

Abstract

PURPOSE: To assess physicians' evaluation of quality, clinical impact and ranking of Norwegian drug information centres (DICs) with regard to drug use during pregnancy.
METHODS: Questionnaires were submitted consecutively to all physicians who consulted a Norwegian DIC in 2006 for information on patient-specific drug use during pregnancy.
RESULTS: Of the 162 questionnaires sent out, 123 (76%) were returned and 117 were included in the analysis. All of the responding physicians reported that the DICs provided high-quality service in terms of providing information on drug use during pregnancy, and 92% stated that the answer from the DICs had a clinical impact. The DICs were ranked highest among the different sources providing information, and general practitioners (GP) ranked the information provided by DICs significantly higher than hospital physicians (HP).
CONCLUSIONS: Physicians consider the information provided by Norwegian DICs on drug use during pregnancy to be of high quality and of significant clinical impact. The DICs were ranked highest as a source of information among GP, suggesting that the need for prescribing support is influenced by the workplace.

Entities:  

Mesh:

Year:  2008        PMID: 19052735     DOI: 10.1007/s00228-008-0593-4

Source DB:  PubMed          Journal:  Eur J Clin Pharmacol        ISSN: 0031-6970            Impact factor:   2.953


  30 in total

1.  [How do Norwegian dermatologists keep themselves professionally updated?].

Authors:  P J Gjersvik; M Nylenna; O G Aasland
Journal:  Tidsskr Nor Laegeforen       Date:  2001-12-10

Review 2.  The effectiveness of Teratology Information Services (TIS).

Authors:  Rebecca L Hancock; Gideon Koren; Adrienne Einarson; Wendy J Ungar
Journal:  Reprod Toxicol       Date:  2006-11-18       Impact factor: 3.143

3.  [Information sources and prescribing in the Lisbon region].

Authors:  Cláudia Furtado; João A Pereira
Journal:  Acta Med Port       Date:  2007-01-23

4.  Prescription drug use among fathers and mothers before and during pregnancy. A population-based cohort study of 106,000 pregnancies in Norway 2004-2006.

Authors:  Anders Engeland; Jørgen G Bramness; Anne Kjersti Daltveit; Marit Rønning; Svetlana Skurtveit; Kari Furu
Journal:  Br J Clin Pharmacol       Date:  2008-02-20       Impact factor: 4.335

5.  Advice on drug safety in pregnancy: are there differences between commonly used sources of information?

Authors:  Sofia K Frost Widnes; Jan Schjøtt
Journal:  Drug Saf       Date:  2008       Impact factor: 5.606

6.  Impact of the dial access drug information service on patient outcome.

Authors:  P S Melnyk; Y M Shevchuk; A J Remillard
Journal:  Ann Pharmacother       Date:  2000-05       Impact factor: 3.154

7.  Drug labeling and risk perceptions of teratogenicity: a survey of pregnant Canadian women and their health professionals.

Authors:  M Pole; A Einarson; N Pairaudeau; T Einarson; G Koren
Journal:  J Clin Pharmacol       Date:  2000-06       Impact factor: 3.126

8.  Prevention of unnecessary pregnancy terminations by counselling women on drug, chemical, and radiation exposure during the first trimester.

Authors:  G Koren; A Pastuszak
Journal:  Teratology       Date:  1990-06

9.  Impact of drug information services on patient care.

Authors:  A A Cardoni; T J Thompson
Journal:  Am J Hosp Pharm       Date:  1978-10

10.  Influences on GPs' decision to prescribe new drugs-the importance of who says what.

Authors:  Helen Prosser; Solomon Almond; Tom Walley
Journal:  Fam Pract       Date:  2003-02       Impact factor: 2.267

View more
  6 in total

1.  Drugs and Birth Defects: a knowledge database providing risk assessments based on national health registers.

Authors:  Ulrika Nörby; Karin Källén; Birgit Eiermann; Seher Korkmaz; Birger Winbladh; Lars L Gustafsson
Journal:  Eur J Clin Pharmacol       Date:  2012-09-26       Impact factor: 2.953

Review 2.  Norwegian drug information centres strongly promote person-centred and personalised medicine: a brief report on the achievements and strategy.

Authors:  Jan Schjøtt
Journal:  EPMA J       Date:  2019-04-30       Impact factor: 6.543

3.  A question-answer pair (QAP) database integrated with websites to answer complex questions submitted to the Regional Medicines Information and Pharmacovigilance Centres in Norway (RELIS): a descriptive study.

Authors:  Jan Schjøtt; Linda A Reppe; Pål-Didrik H Roland; Tone Westergren
Journal:  BMJ Open       Date:  2012-03-15       Impact factor: 2.692

4.  Multiple information sources and consequences of conflicting information about medicine use during pregnancy: a multinational Internet-based survey.

Authors:  Katri Hämeen-Anttila; Hedvig Nordeng; Esa Kokki; Johanna Jyrkkä; Angela Lupattelli; Kirsti Vainio; Hannes Enlund
Journal:  J Med Internet Res       Date:  2014-02-20       Impact factor: 5.428

5.  Questions about complementary and alternative medicine to the Regional Medicines Information and Pharmacovigilance Centres in Norway (RELIS): a descriptive pilot study.

Authors:  Jan Schjøtt; Hilde Erdal
Journal:  BMC Complement Altern Med       Date:  2014-02-14       Impact factor: 3.659

6.  Beliefs and Risk Awareness on Medications Among Pregnant Women Attending the Antenatal Care Unit in Ethiopia University Hospital. Overestimating the Risks Is Another Dread.

Authors:  Yonas Getaye Tefera; Begashaw Melaku Gebresillassie; Amanual Getnet Mersha; Sewunet Admasu Belachew
Journal:  Front Public Health       Date:  2020-03-03
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.